HomeCompareACCD vs ARCC

ACCD vs ARCC: Dividend Comparison 2026

ACCD yields 28.49% · ARCC yields 10.82%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACCD wins by $96.7K in total portfolio value
10 years
ACCD
ACCD
● Live price
28.49%
Share price
$7.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$121.3K
Annual income
$15,341.97
Full ACCD calculator →
ARCC
Ares Capital Corporation
● Live price
10.82%
Share price
$17.74
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.16
Full ARCC calculator →

Portfolio growth — ACCD vs ARCC

📍 ACCD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodACCDARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ACCD + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ACCD pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACCD
Annual income on $10K today (after 15% tax)
$2,421.65/yr
After 10yr DRIP, annual income (after tax)
$13,040.67/yr
ARCC
Annual income on $10K today (after 15% tax)
$919.95/yr
After 10yr DRIP, annual income (after tax)
$0.99/yr
At 15% tax rate, ACCD beats the other by $13,039.69/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACCD + ARCC for your $10,000?

ACCD: 50%ARCC: 50%
100% ARCC50/50100% ACCD
Portfolio after 10yr
$72.9K
Annual income
$7,671.57/yr
Blended yield
10.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

ACCD
Analyst Ratings
7
Buy
13
Hold
Consensus: Hold
Price Target
$13.97
+99.0% upside vs current
Range: $5.00 — $52.00
Altman Z
-1.1
Piotroski
4/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+23.3% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACCD buys
0
ARCC buys
0
No recent congressional trades found for ACCD or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricACCDARCC
Forward yield28.49%10.82%
Annual dividend / share$2.00$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$121.3K$24.5K
Annual income after 10y$15,341.97$1.16
Total dividends collected$81.1K$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusHoldBuy
Analyst price target$13.97$21.88

Year-by-year: ACCD vs ARCC ($10,000, DRIP)

YearACCD PortfolioACCD Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$13,549$2,849.00$11,381$541.15+$2.2KACCD
2$18,105$3,607.58$12,621$284.08+$5.5KACCD
3$23,878$4,505.31$13,827$145.31+$10.1KACCD
4$31,102$5,553.08$15,062$73.43+$16.0KACCD
5$40,039$6,760.03$16,364$36.89+$23.7KACCD
6$50,975$8,133.20$17,757$18.49+$33.2KACCD
7$64,221$9,677.21$19,258$9.25+$45.0KACCD
8$80,110$11,394.16$20,880$4.63+$59.2KACCD
9$99,002$13,283.47$22,636$2.32+$76.4KACCD
10$121,274$15,341.97$24,539$1.16+$96.7KACCD

ACCD vs ARCC: Complete Analysis 2026

ACCDStock

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.

Full ACCD Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this ACCD vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACCD vs SCHDACCD vs JEPIACCD vs OACCD vs KOACCD vs MAINACCD vs HTGCACCD vs GBDCACCD vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.